NVS Today - Aug 10: FDA Approval Buzz
Impossibile aggiungere al carrello
Puoi avere soltanto 50 titoli nel carrello per il checkout.
Riprova più tardi
Riprova più tardi
Rimozione dalla Lista desideri non riuscita.
Riprova più tardi
Non è stato possibile aggiungere il titolo alla Libreria
Per favore riprova
Non è stato possibile seguire il Podcast
Per favore riprova
Esecuzione del comando Non seguire più non riuscita
-
Letto da:
-
Di:
A proposito di questo titolo
So, what went down? Well, Novartis barely moved today. It’s kinda like watching paint dry, you know? But there’s some buzz in the air about their drug Pluvicto getting FDA approval. That’s a big deal! It’s like a spotlight shining on them again.
Now, why did the stock react the way it did? Honestly, it looks like investors are still trying to wrap their heads around what this approval means for the company’s future. Some folks think it could really boost their sales, while others are just sitting back and waiting to see how this plays out. Plus, there’s chatter about Dr. Reddy’s stopping the marketing of Novartis brands starting in October, so that’s probably not helping the mood either.
Oh, and just so you know, JP Morgan is still keeping a Buy rating on the stock. So, there’s that! It’s always good to have some cheerleaders in your corner, right?
To wrap it up, Novartis had a quiet day with a little FDA excitement mixed in. Just keep an eye on how things evolve with Pluvicto and all the other noise around them. Remember, I'm just here to share the info and keep it fun. No financial advice from me! Catch you later!
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione